Renaissance Technologies's NVS Position Overview
Renaissance Technologies (via Renaissance Technologies LLC) currently holds 1.88 M shares of Novartis AG (NVS) worth $240.81 M, representing 0.32% of the portfolio. First purchased in 2013-Q3, this long-term strategic position has been held for 49 quarters.
Based on 13F filings since 2013, Renaissance Technologies has maintained a long-term strategic position in NVS, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2018, adding 2.03 M shares. Largest reduction occurred in Q1 2021, reducing 2.39 M shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies's Novartis (NVS) Holding Value Over Time
Track share changes against reported price movement
Quarterly Novartis (NVS) Trades by Renaissance Technologies
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2013 | +473,407 | New Buy | 473,407 | $68.74 |
| Q4 2013 | +262,370 | Add 55.42% | 735,777 | $72.02 |
| Q1 2014 | -628,641 | Reduce 85.44% | 107,136 | $76.18 |
| Q2 2014 | -91,512 | Reduce 85.42% | 15,624 | $81.09 |
| Q3 2014 | +303,440 | Add 1942.14% | 319,064 | $84.35 |
| Q4 2014 | +641,589 | Add 201.08% | 960,653 | $83.03 |
| Q1 2015 | +409,681 | Add 42.65% | 1.37 M | $88.36 |
| Q2 2015 | -46,091 | Reduce 3.36% | 1.32 M | $88.12 |
| Q3 2015 | +553,313 | Add 41.78% | 1.88 M | $82.37 |
| Q4 2015 | +1.57 M | Add 83.74% | 3.45 M | $77.10 |
| Q1 2016 | +193,403 | Add 5.61% | 3.64 M | $64.91 |
| Q2 2016 | -1.12 M | Reduce 30.75% | 2.52 M | $73.93 |
| Q3 2016 | +284,022 | Add 11.26% | 2.81 M | $70.75 |
| Q4 2016 | -254,557 | Reduce 9.07% | 2.55 M | $65.27 |
| Q1 2017 | +191,392 | Add 7.50% | 2.74 M | $66.55 |
| Q2 2017 | -1.1 M | Reduce 40.02% | 1.65 M | $74.79 |
| Q3 2017 | -33,815 | Reduce 2.05% | 1.61 M | $76.93 |
| Q4 2017 | +303,441 | Add 18.83% | 1.92 M | $75.23 |
| Q1 2018 | +357,787 | Add 18.68% | 2.27 M | $72.45 |
| Q2 2018 | +2.03 M | Add 89.34% | 4.3 M | $67.69 |
| Q3 2018 | -992,001 | Reduce 23.05% | 3.31 M | $77.20 |
| Q4 2018 | +590,476 | Add 17.83% | 3.9 M | $76.89 |
| Q1 2019 | -314,710 | Reduce 8.07% | 3.59 M | $86.15 |
| Q2 2019 | +481,975 | Add 13.44% | 4.07 M | $91.31 |
| Q3 2019 | +1.14 M | Add 27.91% | 5.21 M | $86.90 |
| Q4 2019 | +1.4 M | Add 26.82% | 6.6 M | $94.69 |
| Q1 2020 | +1.89 M | Add 28.63% | 8.49 M | $82.45 |
| Q2 2020 | -196,800 | Reduce 2.32% | 8.29 M | $87.34 |
| Q3 2020 | -1.61 M | Reduce 19.44% | 6.68 M | $86.96 |
| Q4 2020 | -1.92 M | Reduce 28.79% | 4.76 M | $94.43 |
| Q1 2021 | -2.39 M | Reduce 50.19% | 2.37 M | $85.48 |
| Q2 2021 | +39,600 | Add 1.67% | 2.41 M | $91.24 |
| Q3 2021 | +897,298 | Add 37.23% | 3.31 M | $81.78 |
| Q4 2021 | +420,333 | Add 12.71% | 3.73 M | $87.47 |
| Q1 2022 | -346,400 | Reduce 9.29% | 3.38 M | $87.75 |
| Q2 2022 | +402,200 | Add 11.90% | 3.78 M | $84.53 |
| Q3 2022 | -601,500 | Reduce 15.90% | 3.18 M | $76.01 |
| Q4 2022 | +239,100 | Add 7.51% | 3.42 M | $0.09 |
| Q1 2023 | -373,526 | Reduce 10.92% | 3.05 M | $0.09 |
| Q2 2023 | -692,599 | Reduce 22.73% | 2.35 M | $0.10 |
| Q3 2023 | +282,000 | Add 11.98% | 2.64 M | $101.86 |
| Q4 2023 | +201,237 | Add 7.63% | 2.84 M | $100.97 |
| Q1 2024 | +102,500 | Add 3.61% | 2.94 M | $96.73 |
| Q2 2024 | -440,800 | Reduce 14.99% | 2.5 M | $106.46 |
| Q3 2024 | -199,104 | Reduce 7.96% | 2.3 M | $115.02 |
| Q4 2024 | +368,171 | Add 16.00% | 2.67 M | $97.31 |
| Q1 2025 | -381,598 | Reduce 14.30% | 2.29 M | $111.48 |
| Q2 2025 | +10,900 | Add 0.48% | 2.3 M | $121.01 |
| Q3 2025 | -420,320 | Reduce 18.29% | 1.88 M | $128.24 |
Renaissance Technologies's Novartis Investment FAQs
Renaissance Technologies first purchased Novartis AG (NVS) in Q3 2013, acquiring 473,407 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies has held Novartis AG (NVS) for 49 quarters since Q3 2013.
Renaissance Technologies's largest addition to Novartis AG (NVS) was in Q2 2018, adding 4,303,617 shares worth $291.3 M.
According to the latest 13F filing for Q3 2025, Renaissance Technologies's firm, Renaissance Technologies LLC, owns 1,877,831 shares of Novartis AG (NVS), valued at approximately $240.81 M.
As of the Q3 2025 filing, Novartis AG (NVS) represents approximately 0.32% of Renaissance Technologies's publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies's peak holding in Novartis AG (NVS) was 8,491,408 shares, as reported at the end of Q1 2020.